Mechanical Cardiopulmonary Resuscitation (CPR) Market Global Report 2026

The mechanical cardiopulmonary resuscitation (CPR) market size has grown rapidly in recent years. It will grow from $0.78 billion in 2025 to $0.86 billion in 2026 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to increasing incidence of cardiac arrest cases, rising demand for consistent CPR quality, growing adoption of automated emergency medical equipment, expanding emergency medical services infrastructure, increasing awareness of advanced life support technologies.

The mechanical cardiopulmonary resuscitation (CPR) market size is expected to see rapid growth in the next few years. It will grow to $1.26 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to increasing integration of smart sensors in CPR devices, rising adoption of portable resuscitation systems, growing demand for automated emergency response solutions, expanding use of mechanical CPR during patient transportation, increasing investment in advanced cardiac care equipment. Major trends in the forecast period include increasing adoption of automated chest compression systems, growing development of portable mechanical cpr devices, rising integration of advanced feedback and monitoring technologies, expansion of mechanical cpr use during emergency patient transport, increasing demand for battery powered resuscitation devices.

The increasing incidence of sudden cardiac arrest cases is expected to drive the growth of the mechanical cardiopulmonary resuscitation (CPR) market going forward. Sudden cardiac arrest is a life-threatening medical emergency in which the heart unexpectedly stops beating effectively due to an electrical disturbance, resulting in an immediate loss of blood circulation that requires rapid cardiopulmonary resuscitation and defibrillation. The increasing incidence of sudden cardiac arrest cases is fueled by the growing prevalence of cardiovascular diseases, which elevates the risk of fatal cardiac rhythm abnormalities among the population. The rising occurrence of sudden cardiac arrest cases is driving demand for mechanical cardiopulmonary resuscitation devices, as they provide consistent and high-quality chest compressions during emergency resuscitation, enhancing treatment efficiency and supporting improved patient outcomes. For instance, in February 2026, according to the American Heart Association (AHA), a US-based nonprofit organization, sudden cardiac arrest accounted for 380,349 deaths in the United States in 2023, emphasizing the significant burden of sudden cardiac arrest cases. Therefore, the increasing incidence of sudden cardiac arrest cases is supporting the growth of the mechanical cardiopulmonary resuscitation (CPR) market.

Leading companies operating in the mechanical cardiopulmonary resuscitation (CPR) market are concentrating on achieving advanced regulatory certifications to enhance product quality, safety, and compliance while strengthening integrated emergency care solutions. Medical Device Regulation (MDR) certification is a European regulatory approval that confirms a medical device meets strict safety, performance, and quality requirements for commercialization in the European Union. For example, in May 2024, GS Elektromedizinische Geräte G. Stemple GmbH, a Germany-based medical technology company operating under the corpuls brand, obtained Medical Device Regulation (MDR) certification for its corpuls3 and corpuls3T defibrillators. The company integrated these devices with its MDR-certified Corpuls CPR mechanical chest compression device and Corpuls.mission LIVE telemedicine software. This integrated platform improves emergency cardiac care by supporting faster response, dependable performance, and efficient patient management.

In April 2023, Nordic Capital, a Sweden-based private equity firm, acquired a majority stake in Corpuls for an undisclosed value. Through this acquisition, Nordic Capital partnered with the founding family of corpuls to drive the company’s long-term development while ensuring the family continued to have representation on the management board. The investment is focused on enhancing innovation, expanding telemedicine capabilities, strengthening the company’s footprint in the hospital sector, and enabling further international growth. Corpuls is a Germany-based manufacturer of the mechanical CPR device Corpuls CPR.

Major companies operating in the mechanical cardiopulmonary resuscitation (cpr) market report are Stryker Corporation, ZOLL Medical Corporation, Defibtech LLC, SCHILLER AG, Ambulanc (Shenzhen) Tech. Co. Ltd., SunLife Science, Michigan Instruments, Guangzhou Yueshen Medical, Dexup Healthcare.

North America was the dominant region in the mechanical cardiopulmonary resuscitation (CPR) market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the mechanical cardiopulmonary resuscitation (CPR) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the mechanical cardiopulmonary resuscitation (CPR) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.